Sanofi India Fact Sheet, Sanofi India Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sanofi India Fact Sheet    (HOCM)


Learn: How to Potentially Accumulate Rs 7 Crore in Wealth Over the Long-term


Here is the latest financial fact sheet of Sanofi India. For more details, see the Sanofi India quarterly results and Sanofi India share price and chart. For a sector overview, read our pharmaceuticals sector report.

SANOFI INDIA Price History

Price Rs 7,751.1
Mkt Cap Rs m 178,508
Vol '000 0.6
P/E X 39.5
P/CF X 36.9
EPS (TTM) Rs 196.2
% ch % -1.3
No. of shares m 23.03
% ch week % 2.0
% ch 1-mth % -4.3
% ch 12-mth % -2.3
52 week H/L Rs 8,999.0/7,322.1
(As on May 12, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SANOFI INDIA Financials

No. of Mths
Year Ending
12
Dec-14
12
Dec-15
12
Dec-16
12
Dec-17
12
Dec-18
5-Yr Chart
Click to enlarge
SANOFI INDIA EQUITY SHARE DATA
High Rs3,8004,5214,5604,9456,840 
Low Rs2,5003,4454,4003,9014,630 
Sales per share (Unadj.) Rs858.7952.31,028.51,081.81,203.1 
Earnings per share (Unadj.) Rs114.5139.6132.1141.6165.3 
Diluted earnings per shareRs114.5139.6132.1141.6165.3 
Cash flow per share (Unadj.) Rs156.4188.7183.7185.9209.9 
Dividends per share (Unadj.) Rs45.0065.0068.0071.0084.00 
Adj. dividends per shareRs45.0065.0068.0071.0084.00 
Dividend yield (eoy) %1.41.61.51.61.5 
Book value per share (Unadj.) Rs645.2706.5753.6879.9963.6 
Adj. book value per shareRs645.2706.5753.6879.9963.6 
Shares outstanding (eoy) m23.0323.0323.0323.0323.03 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x3.74.24.44.14.8 
Avg P/E ratio x27.528.533.931.234.7 
P/CF ratio (eoy) x20.121.124.423.827.3 
Price / Book Value ratio x4.95.65.95.06.0 
Dividend payout %39.346.651.550.250.8 
Avg Mkt Cap Rs m72,54591,724103,174101,862132,078 
No. of employees `0003.43.73.63.23.3 
Total wages/salary Rs m2,8823,3333,5533,6854,068 
Avg. sales/employee Rs Th5,735.25,987.06,537.77,691.98,393.8 
Avg. wages/employee Rs Th836.0909.9980.71,137.71,232.4 
Avg. net profit/employee Rs Th764.5877.7839.61,006.51,153.0 
SANOFI INDIA INCOME DATA
Net Sales Rs m19,77521,93023,68624,91427,708 
Other income Rs m643514664807897 
Total revenues Rs m20,41822,44424,35025,72128,605 
Gross profit Rs m3,3894,5915,3515,3726,235 
Depreciation Rs m9661,1301,1881,0221,027 
Interest Rs m5423117 
Profit before tax Rs m3,0613,9704,8045,1466,098 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m666839000 
Tax Rs m1,0901,5941,7621,8862,292 
Profit after tax Rs m2,6363,2153,0423,2603,806 
Gross profit margin %17.120.922.621.622.5 
Effective tax rate %35.640.136.736.637.6 
Net profit margin %13.314.712.813.113.7 
SANOFI INDIA BALANCE SHEET DATA
Current assets Rs m12,62812,43715,75314,43815,922 
Current liabilities Rs m6,5584,9455,0216,0176,235 
Net working cap to sales %30.734.245.333.835.0 
Current ratio x1.92.53.12.42.6 
Inventory Days Days8880766164 
Debtors Days Days2124222921 
Net fixed assets Rs m8,5828,7718,0987,9917,539 
Share capital Rs m230230230230230 
"Free" reserves Rs m14,55916,00417,08820,03421,962 
Net worth Rs m14,85816,27217,35620,26422,192 
Long term debt Rs m00000 
Total assets Rs m22,27624,11425,41227,77729,839 
Interest coverage x638.6993.5209.9468.8872.1 
Debt to equity ratio x00000 
Sales to assets ratio x0.90.90.90.90.9 
Return on assets %11.913.312.111.812.8 
Return on equity %17.719.817.516.117.2 
Return on capital %25.129.627.825.427.5 
Exports to sales %24.224.224.500 
Imports to sales %36.926.128.000 
Exports (fob) Rs m4,7885,3125,80100 
Imports (cif) Rs m7,2985,7206,62700 
Fx inflow Rs m5,4956,6807,1456,3067,587 
Fx outflow Rs m8,0456,5876,8465,2577,145 
Net fx Rs m-2,550932991,049442 
SANOFI INDIA CASH FLOW
From Operations Rs m 2,650 2,132 3,221 4,351 3,739 
From Investments Rs m 613 359 -1,550 -787 -731 
From Financial Activity Rs m -1,217 -1,470 -1,802 -1,884 -1,972 
Net Cashflow Rs m 2,046 1,021 -131 1,680 1,036 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 60.4%
Indian inst/Mut Fund 14.4%
FIIs 14.6%
ADR/GDR 0.0%
Free float 10.5%
Shareholders 15,184
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Aventis House, 54/A, Mathuradas Vasanji Road, Andheri (E), Mumbai-93
E-MAIL k.subramani@sanofi.com WEB www.sanofiindialtd.com
TELEPHONE (022) 2827 8000 FAX (022) 2837 0939
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR S. R. Batliboi & Co.
CHM: Vijay Mallya COMP SEC: K. Subramani YEAR OF INC: 1956 BSE CODE: 500674 FV (Rs): 10 DIV YIELD (%): 1.1

Read: SANOFI INDIA 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   JUBILANT PHARMOVA   INDOCO REMEDIES  CIPLA  ORCHID PHARMA  GSK PHARMA  

Compare SANOFI INDIA With:   JUBILANT PHARMOVA   INDOCO REMEDIES  CIPLA  ORCHID PHARMA  GSK PHARMA  

Compare SANOFI INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  




Today's Market

Sensex Falls 471 Points, Nifty Ends Below 14,700; Tata Steel & JSW Steel Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Views on news

SANOFI INDIA Announces Quarterly Results (2QFY21); Net Profit Up 5.0% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 5.0% YoY). Sales on the other hand came in at Rs 7 bn (down 11.9% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY21); Net Profit Up 39.9% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 39.9% YoY). Sales on the other hand came in at Rs 7 bn (down 5.0% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SANOFI INDIA

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS